International Aids Vaccine Initiative
π°πͺKenya
A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- HIVHIV Infections
- Interventions
- Biological: Ad35-GRIN/ENVBiological: Ad35-GRIN
- First Posted Date
- 2009-02-25
- Last Posted Date
- 2012-04-25
- Lead Sponsor
- International AIDS Vaccine Initiative
- Target Recruit Count
- 56
- Registration Number
- NCT00851383
- Locations
- πΊπΈ
University of Rochester Medical Center, Rochester, New York, United States
Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine
Phase 1
Completed
- Conditions
- HIV Infection
- Interventions
- Biological: tgAAC09
- First Posted Date
- 2007-06-04
- Last Posted Date
- 2013-01-16
- Lead Sponsor
- International AIDS Vaccine Initiative
- Target Recruit Count
- 80
- Registration Number
- NCT00482027
- Locations
- π§πͺ
SGS Biopharma, Antwerpen, Belgium
π§πͺSt. Pierre University Hospital, Brussels, Belgium
π©πͺUniveristy of Bonn, Bonn, Germany
Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults
Phase 1
Completed
- Conditions
- HIV Infection
- Interventions
- Biological: ADMVA
- First Posted Date
- 2005-11-11
- Last Posted Date
- 2013-02-11
- Lead Sponsor
- International AIDS Vaccine Initiative
- Target Recruit Count
- 48
- Registration Number
- NCT00252148
- Locations
- πΊπΈ
Rockefeller University Hospital, New York, New York, United States
πΊπΈUniversity of Rochester Medical Center, Rochester, New York, United States
Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults
Phase 1
Completed
- Conditions
- HIV Infection
- Interventions
- Biological: ADVAX
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2013-02-11
- Lead Sponsor
- International AIDS Vaccine Initiative
- Target Recruit Count
- 45
- Registration Number
- NCT00249106
- Locations
- πΊπΈ
Rockefeller University Hospital, New York, New York, United States
πΊπΈUniversity of Rochester Medical Center, Rochester, New York, United States